• John Ciccio appointed as new CEO and Managing Director
• Outgoing CEO Rick Ratliff to support transition
• Ciccio brings 12 years of experience with Adheris Health, including as President and CEO from 2019-2022

MedAdvisor Limited (ASX:MDR) has announced the appointment of John Ciccio as its new CEO and Managing Director, effective immediately. Ciccio replaces outgoing CEO and Managing Director Rick Ratliff, who will remain in an advisory capacity to ensure a smooth transition. Ciccio brings a collective 12 years of past tenure with Adheris Health (the US business acquired by MedAdvisor in 2020), including serving as President and CEO from 2019-2022. During his time at Adheris Health, Ciccio spearheaded the launch of THRiV, the company's intelligent patient management platform, drove revenues from US$25 million to approaching US$40 million, oversaw the sale of Adheris Health to MedAdvisor, and positioned the future company for scalable growth across global markets. Interim Chair Kate Hill stated that Ciccio's previous experience with the company gives him a deep understanding of its operations, people, and strategic priorities, allowing him to step seamlessly into the role and provide steady, decisive leadership. Outgoing CEO Rick Ratliff expressed pride in the company's achievements under his leadership, including completing the divestment of the ANZ business, extinguishing all debt obligations, expanding and broadening the health program pipeline, and developing and implementing a major technology transformation. Ratliff noted that it is the right time to hand over leadership to Ciccio, who brings a deep understanding of the business and a long history of contributing to its success.

Ciccio stated that he is looking forward to working with the talented team to build on the strong foundation laid by Ratliff and to continue delivering real value for patients and partners.